Skip to content

Clinical trials

Wilms Tumor trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Wilms Tumor Country / region: United States Clear all

156 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20006
20016
20024
20034
20044
20055
200610
20076
20087
20095
20108
20115
20126
20132
20142
20154
20166
201712
20185
20193
20205
20217
20225
20231
20241
20253
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed100
Recruiting17
Active, not recruiting15
Terminated13
Unknown status5
Withdrawn5
No longer available1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)31
Children's Oncology Group22
Fred Hutchinson Cancer Center10
Memorial Sloan Kettering Cancer Center8
St. Jude Children's Research Hospital6
Baylor College of Medicine4
Emory University4
M.D. Anderson Cancer Center4
National Institutes of Health Clinical Center (CC)4
Sumitomo Pharma America, Inc.4

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Wilms Tumor156
Neuroblastoma97
Sarcoma75
Osteosarcoma56
Rhabdomyosarcoma55
Sarcoma, Ewing47
Lymphoma, Non-Hodgkin38
Medulloblastoma37
Neuroectodermal Tumors, Primitive, Peripheral37
Rhabdoid Tumor36

Trials

Showing 1 to 25 of 156. Each trial links to its page on Pharma Observatory.

56 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.